{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:34:08Z","timestamp":1793133248423,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cbi.2020.108975","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T05:59:12Z","timestamp":1581055152000},"page":"108975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease"],"prefix":"10.1016","volume":"317","author":[{"given":"Gaurav","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseem","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Gothwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa A.A.","family":"Aljabali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Dureja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parteek","family":"Prasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak N.","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtaza M.","family":"Tambuwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh K.","family":"Chellappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2020.108975_bib1","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts","volume":"79","author":"Astor","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2020.108975_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/M14-0488","article-title":"Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study","volume":"162","author":"Anderson","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cbi.2020.108975_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.2004080656","article-title":"Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study","volume":"16","author":"Muntner","year":"2005","journal-title":"J. Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"key":"10.1016\/j.cbi.2020.108975_bib4","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2020.108975_bib5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group","volume":"329","author":"Lewis","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2020.108975_bib6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease","volume":"363","author":"Appel","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2020.108975_bib7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2020.108975_bib8","article-title":"Dual RAAS blocker trial stopped prematurely","volume":"10","author":"Cully","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.cbi.2020.108975_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCRESAHA.117.310978","article-title":"Multifunctional role of chymase in acute and chronic tissue injury and remodeling","volume":"122","author":"Dell'Italia","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2020.108975_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11906-019-0937-8","article-title":"Revisiting the brain renin-angiotensin system-focus on novel therapies","volume":"21","author":"Ren","year":"2019","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.cbi.2020.108975_bib11","article-title":"An update on the tissue renin angiotensin system and its role in physiology and pathology","volume":"6","author":"Nehme","year":"2019","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.cbi.2020.108975_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.23736\/S0031-0808.18.03435-3","article-title":"Nanoparticle-based therapies as a modality in treating wounds and preventing biofilm [Letter to the editor]","volume":"60","author":"Dua","year":"2018","journal-title":"Panminerva Med.: J. Intern. Med."},{"key":"10.1016\/j.cbi.2020.108975_bib13","first-page":"752","article-title":"Anticonvulsant effect of liraglutide, GLP-1 agonist by averting a change in GABA and brain glutathione level on picrotoxin-induced seizures","volume":"16","author":"Gupta","year":"2017","journal-title":"EXCLI J."},{"key":"10.1016\/j.cbi.2020.108975_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/bab.1799","article-title":"Combinational effect of angiotensin receptor blocker and folic acid therapy on uric acid and creatinine level in hyperhomocysteinemia-associated hypertension","volume":"66","author":"Singh","year":"2019","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.cbi.2020.108975_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1615\/CritRevEukaryotGeneExpr.2018021364","article-title":"Embarking effect of ACE2-angiotensin 1-7\/Mas receptor Axis in Benign prostate hyperplasia","volume":"28","author":"Singh","year":"2018","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.cbi.2020.108975_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/frne.1995.1002","article-title":"The angiotensin IV system: functional implications","volume":"16","author":"Wright","year":"1995","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.cbi.2020.108975_bib17","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/01.RES.0000130654.56599.40","article-title":"Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist","volume":"94","author":"Lochard","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2020.108975_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0031-9384(88)90033-9","article-title":"Behavioral effects of angiotensin II and angiotensin II-(4-8)-pentapeptide in rats","volume":"44","author":"Braszko","year":"1988","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.cbi.2020.108975_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3317\/jraas.2001.032","article-title":"Bioactive angiotensin peptides: focus on angiotensin IV","volume":"2","author":"Mustafa","year":"2001","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS : J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.cbi.2020.108975_bib20","doi-asserted-by":"crossref","first-page":"F707","DOI":"10.1152\/ajprenal.00007.2002","article-title":"TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells, American journal of physiology","volume":"283","author":"Gore-Hyer","year":"2002","journal-title":"Ren. Physiol."},{"key":"10.1016\/j.cbi.2020.108975_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1681\/ASN.V13165","article-title":"Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes","volume":"13","author":"Arrondel","year":"2002","journal-title":"J. Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"key":"10.1016\/j.cbi.2020.108975_bib22","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-019-44194-3","article-title":"Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease","volume":"9","author":"Kang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2020.108975_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1556\/1646.8.2016.2.4","article-title":"Norfloxacin and metronidazole topical formulations for effective treatment of bacterial infections and burn wounds","volume":"8","author":"Dua","year":"2016","journal-title":"Intervent Med. Appl. Sci."},{"key":"10.1016\/j.cbi.2020.108975_bib24","doi-asserted-by":"crossref","DOI":"10.1615\/JEnvironPatholToxicolOncol.2017019457","article-title":"Nephrotoxicity in rats exposed to paracetamol: the protective role of moralbosteroid, a steroidal glycoside","volume":"36","author":"Gupta","year":"2017","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.cbi.2020.108975_bib25","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis","volume":"40","author":"Kopp","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cbi.2020.108975_bib26","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1093\/ndt\/gfp316","article-title":"Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD","volume":"24","author":"Freedman","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cbi.2020.108975_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11010-012-1489-2","article-title":"Effect of combination of renin inhibitor and Mas-receptor agonist in DOCA-salt-induced hypertension in rats","volume":"373","author":"Singh","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2020.108975_bib28","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1681\/ASN.2006040356","article-title":"Renin-angiotensin-aldosterone system and progression of renal disease","volume":"17","author":"Ruster","year":"2006","journal-title":"J. Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"key":"10.1016\/j.cbi.2020.108975_bib29","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3390\/jcm4111908","article-title":"Renin-angiotensin-aldosterone system blockade in diabetic nephropathy. Present evidences","volume":"4","author":"Lozano-Maneiro","year":"2015","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cbi.2020.108975_bib30","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/bmj.38237.585000.7C","article-title":"Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review","volume":"329","author":"Strippoli","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.cbi.2020.108975_bib31","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1681\/ASN.V12122832","article-title":"ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a <em>Post hoc<\/em> analysis of the REIN trial results","volume":"12","author":"Ruggenenti","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cbi.2020.108975_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1185\/030079903125003017","article-title":"AII antagonists in hypertension, heart failure, and diabetic nephropathy: focus on losartan","volume":"20","author":"Ferrario","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.cbi.2020.108975_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2215\/CJN.07821109","article-title":"Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors","volume":"5","author":"Weir","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cbi.2020.108975_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213192","article-title":"Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: a general practice-based, observational study","volume":"14","author":"Jun","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.cbi.2020.108975_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mce.2011.07.034","article-title":"Acute and chronic regulation of aldosterone production","volume":"350","author":"Hattangady","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cbi.2020.108975_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","volume":"113","author":"Marney","year":"2007","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.cbi.2020.108975_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00424-008-0616-0","article-title":"Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly?","volume":"458","author":"Gekle","year":"2009","journal-title":"Pflueg. Arch. Eur. J. Physiol."},{"key":"10.1016\/j.cbi.2020.108975_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145946","article-title":"Aldosterone induces renal fibrosis and inflammatory M1-macrophage subtype via mineralocorticoid receptor in rats","volume":"11","author":"Mart\u00edn-Fern\u00e1ndez","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.cbi.2020.108975_bib39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-981-13-8871-2_15","article-title":"Role of aldosterone in renal fibrosis","volume":"1165","author":"Shrestha","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cbi.2020.108975_bib40","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2020.108975_bib41","doi-asserted-by":"crossref","first-page":"F887","DOI":"10.1152\/ajprenal.00050.2001","article-title":"Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function","volume":"281","author":"Basile","year":"2001","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cbi.2020.108975_bib42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2020.108975_bib43","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/ndt\/gfy246","article-title":"Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation","volume":"34","author":"Barrera-Chimal","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cbi.2020.108975_bib44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s13596-014-0148-4","article-title":"Hepatoprotective activity of moralbosteroid, a steroidal glycoside isolated from Morus alba","volume":"14","author":"Gupta","year":"2014","journal-title":"Orient. Pharm. Exp. Med."},{"key":"10.1016\/j.cbi.2020.108975_bib45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1872211310666160321123610","article-title":"Pharmacological effect of berberine chloride in propyl thiouracil induced thyroidal dysfunction-a time bound study in female rats","volume":"10","author":"Maurya","year":"2016","journal-title":"Recent Pat. Drug Deliv. Formulation"},{"key":"10.1016\/j.cbi.2020.108975_bib46","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.0.0910457","article-title":"Rise in plasma concentration of aldosterone during long-term angiotensin II suppression","volume":"91","author":"Staessen","year":"1981","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.cbi.2020.108975_bib47","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0735-1097(01)01237-2","article-title":"Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype","volume":"37","author":"Cicoira","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cbi.2020.108975_bib48","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1007\/s00125-004-1542-0","article-title":"Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate","volume":"47","author":"Schjoedt","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2020.108975_bib49","article-title":"Effects of single and dual RAAS blockade therapy on progressive kidney disease transition to CKD in rats","author":"Aggarwal","year":"2019","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.cbi.2020.108975_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/147323000102900103","article-title":"Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy","volume":"29","author":"Sato","year":"2001","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.cbi.2020.108975_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.krcp.2014.09.003","article-title":"MYH9 nephropathy","volume":"34","author":"Oh","year":"2015","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.cbi.2020.108975_bib52","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/01.HYP.0000150159.48992.11","article-title":"Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells","volume":"45","author":"Kohlstedt","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2020.108975_bib53","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.2169\/internalmedicine.2997-19","article-title":"Renin-angiotensin system blockade therapy for early renal involvement in MYH9-related disease with an E1841K mutation","volume":"58","author":"Tanaka","year":"2019","journal-title":"Intern. Med. (Tokyo)"},{"key":"10.1016\/j.cbi.2020.108975_bib54","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.RES.0000217340.40936.53","article-title":"Signaling by the angiotensin-converting enzyme","volume":"98","author":"Fleming","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2020.108975_bib55","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/10253890.2012.710919","article-title":"The legacy of Hans Selye and the origins of stress research: a retrospective 75 years after his landmark brief \u201cLetter\u201d to the Editor# of Nature","volume":"15","author":"Szabo","year":"2012","journal-title":"Stress"},{"key":"10.1016\/j.cbi.2020.108975_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/science.96.2498.450","article-title":"Isolation of adrenocorticotropic hormone from sheep pituitaries","volume":"96","author":"Li","year":"1942","journal-title":"Science"},{"key":"10.1016\/j.cbi.2020.108975_bib57","first-page":"21","article-title":"Aqueous extract of wood ear mushroom, Auricularia polytricha (Agaricomycetes), demonstrated antiepileptic activity against seizure induced by maximal electroshock and isoniazid in experimental animals","author":"Gupta","year":"2019","journal-title":"Int. J. Med. Mushrooms"},{"key":"10.1016\/j.cbi.2020.108975_bib58","series-title":"Oligonucleotide Therapy: an Emerging Focus Area for Drug Delivery in Chronic Inflammatory Respiratory Diseases","author":"Mehta","year":"2019"},{"key":"10.1016\/j.cbi.2020.108975_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2016.00040","article-title":"The potential of ACTH in the genesis of primary aldosteronism","volume":"7","author":"Funder","year":"2016","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cbi.2020.108975_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2016.00072","article-title":"Role of ACTH and other hormones in the regulation of aldosterone production in primary aldosteronism","volume":"7","author":"El Ghorayeb","year":"2016","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cbi.2020.108975_bib61","series-title":"Recent Updates on Neuropharmacological Effects of Luteolin","author":"Gupta","year":"2018"},{"key":"10.1016\/j.cbi.2020.108975_bib62","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.biopha.2018.06.136","article-title":"Emerging landscape in psoriasis management: from topical application to targeting biomolecules","volume":"106","author":"Rapalli","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2020.108975_bib63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0303-7207(99)00051-9","article-title":"Adrenal zonation: clues from 11beta-hydroxylase and aldosterone synthase","volume":"151","author":"Rainey","year":"1999","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cbi.2020.108975_bib64","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/cns.12137","article-title":"Effect of rosiglitazone, a PPAR\u2010\u03b3 ligand on haloperidol\u2010induced catalepsy","volume":"19","author":"Gupta","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cbi.2020.108975_bib65","first-page":"21","article-title":"Role of aqueous extract of the wood ear mushroom, auricularia polytricha (agaricomycetes), in avoidance of haloperidol-lnduced catalepsy via oxidative stress in rats","author":"Liu","year":"2019","journal-title":"Int. J. Med. Mushrooms"},{"key":"10.1016\/j.cbi.2020.108975_bib66","doi-asserted-by":"crossref","first-page":"32656","DOI":"10.1074\/jbc.272.51.32656","article-title":"Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity","volume":"272","author":"Arakane","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2020.108975_bib67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0031-6997(24)01434-0","article-title":"Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases","volume":"52","author":"Kim","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cbi.2020.108975_bib68","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biomag.2013.10.005","article-title":"Anticonvulsant activity of Morusin isolated from Morus alba: modulation of GABA receptor","volume":"4","author":"Gupta","year":"2014","journal-title":"Biomed. Aging Pathol."},{"key":"10.1016\/j.cbi.2020.108975_bib69","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jep.2012.03.013","article-title":"Sedative, antiepileptic and antipsychotic effects of Viscum album L.(Loranthaceae) in mice and rats","volume":"141","author":"Gupta","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cbi.2020.108975_bib70","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.amjmed.2015.05.040","article-title":"Management of hyperkalemia: an update for the internist","volume":"128","author":"Kovesdy","year":"2015","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cbi.2020.108975_bib71","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0014-4886(85)90006-8","article-title":"Changes in membrane potential and potassium and sodium activities during postnatal development of mouse skeletal muscle","volume":"89","author":"Ward","year":"1985","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cbi.2020.108975_bib72","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cbi.2020.108975_bib73","first-page":"257","article-title":"Antimicrobial efficacy of extemporaneously prepared herbal mouth-washes","volume":"9","author":"Dua","year":"2015","journal-title":"Recent Pat. Drug Deliv. Formulation"},{"key":"10.1016\/j.cbi.2020.108975_bib74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.23736\/S0031-0808.17.03386-9","article-title":"Tumor suppressor role of miR-503","volume":"60","author":"Gupta","year":"2018","journal-title":"Panminerva Med."},{"key":"10.1016\/j.cbi.2020.108975_bib75","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Spat","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cbi.2020.108975_bib76","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/j.1460-2075.1988.tb02855.x","article-title":"Angiotensin II-induced stimulation of voltage-dependent Ca2+ currents in an adrenal cortical cell line","volume":"7","author":"Hescheler","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2020.108975_bib77","doi-asserted-by":"crossref","first-page":"C1340","DOI":"10.1152\/ajpcell.1996.271.4.C1340","article-title":"Angiotensin II stimulates T-type Ca2+ channel currents via activation of a G protein, Gi","volume":"271","author":"Lu","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.cbi.2020.108975_bib78","doi-asserted-by":"crossref","first-page":"19943","DOI":"10.1074\/jbc.274.28.19943","article-title":"Angiotensin II negatively modulates L-type calcium channels through a pertussis toxin-sensitive G protein in adrenal glomerulosa cells","volume":"274","author":"Maturana","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2020.108975_bib79","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1177\/153537020322800814","article-title":"Involvement of rho and rho-associated kinase in sphincteric smooth muscle contraction by angiotensin II","volume":"228","author":"Rattan","year":"2003","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.cbi.2020.108975_bib80","doi-asserted-by":"crossref","first-page":"19772","DOI":"10.1074\/jbc.273.31.19772","article-title":"Temporal dispersion of activation of phospholipase C-beta1 and -gamma isoforms by angiotensin II in vascular smooth muscle cells. Role of alphaq\/11, alpha12, and beta gamma G protein subunits","volume":"273","author":"Ushio-Fukai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2020.108975_bib81","doi-asserted-by":"crossref","first-page":"23180","DOI":"10.1074\/jbc.272.37.23180","article-title":"A betagamma dimer derived from G13 transduces the angiotensin AT1 receptor signal to stimulation of Ca2+ channels in rat portal vein myocytes","volume":"272","author":"Macrez","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2020.108975_bib82","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0026-895X(24)23160-6","article-title":"Angiotensin II receptor coupling to phospholipase D is mediated by the betagamma subunits of heterotrimeric G proteins in vascular smooth muscle cells","volume":"55","author":"Ushio-Fukai","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2020.108975_bib83","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ceca.2007.09.001","article-title":"Complex regulation of the TRPC3, 6 and 7 channel subfamily by diacylglycerol and phosphatidylinositol-4,5-bisphosphate","volume":"43","author":"Lemonnier","year":"2008","journal-title":"Cell Calcium"},{"key":"10.1016\/j.cbi.2020.108975_bib84","doi-asserted-by":"crossref","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018027246","article-title":"Herbal medicines in neurodegenerative disorders: an evolutionary approach through novel drug delivery system","volume":"37","author":"Dubey","year":"2018","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.cbi.2020.108975_bib85","first-page":"28","article-title":"Role of the tristetraprolin (zinc finger protein 36 homolog) gene in cancer","author":"Gupta","year":"2018","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.cbi.2020.108975_bib86","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1210\/edrv-10-4-496","article-title":"Role of calcium in angiotensin II-mediated aldosterone secretion","volume":"10","author":"Barrett","year":"1989","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cbi.2020.108975_bib87","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0031-6997(25)06811-5","article-title":"Role of calcium and other mediators in aldosterone secretion from the adrenal glomerulosa cells","volume":"46","author":"Ganguly","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cbi.2020.108975_bib88","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0006-291X(05)80138-X","article-title":"Greater importance of Ca(2+)-calmodulin in maintenance of ang II- and K(+)-mediated aldosterone secretion: lesser role of protein kinase C","volume":"182","author":"Ganguly","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2020.108975_bib89","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0960-0760(96)00052-0","article-title":"Role of calmodulin-dependent protein kinase II in the acute stimulation of aldosterone production","volume":"58","author":"Pezzi","year":"1996","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cbi.2020.108975_bib90","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.1016\/S0021-9258(17)47233-4","article-title":"Correlation between cytosolic free Ca2+ and aldosterone production in bovine adrenal glomerulosa cells. Evidence for a difference in the mode of action of angiotensin II and potassium","volume":"259","author":"Capponi","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2020.108975_bib91","doi-asserted-by":"crossref","first-page":"14448","DOI":"10.1016\/S0021-9258(17)42620-2","article-title":"The temporal integration of the aldosterone secretory response to angiotensin occurs via two intracellular pathways","volume":"259","author":"Kojima","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2020.108975_bib92","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/bj2280069","article-title":"Intracellular calcium and adenosine 3',5'-cyclic monophosphate as mediators of potassium-induced aldosterone secretion","volume":"228","author":"Kojima","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2020.108975_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2016.00072","article-title":"Role of ACTH and other hormones in the regulation of aldosterone production in primary aldosteronism","volume":"7","author":"El Ghorayeb","year":"2016","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cbi.2020.108975_bib94","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/1756-185X.13602","article-title":"Rosmarinic acid attenuates inflammation in experimentally induced arthritis in Wistar rats, using Freund's complete adjuvant","volume":"22","author":"Gautam","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.cbi.2020.108975_bib95","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/0974-8490.129046","article-title":"Anticonvulsant activity of Morus alba and its effect on brain gamma-aminobutyric acid level in rats","volume":"6","author":"Gupta","year":"2014","journal-title":"Pharmacogn. Res."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279720300041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279720300041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:59:23Z","timestamp":1757858363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279720300041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":95,"alternative-id":["S0009279720300041"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2020.108975","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2020.108975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108975"}}